Scope & details
The full contract record, as filed.
Frequently asked questions
Common questions about this contract, answered from the record.
Who was awarded the research grant contract by Oregon Health & Science University?
Melanocortin-4 Receptor Agonists Industry Partner was awarded this research grant contract by Oregon Health & Science University, as recorded on January 22, 2026. The contract value is $300,386.
How much is the Melanocortin-4 Receptor Agonists Industry Partner contract with Oregon Health & Science University worth?
The Melanocortin-4 Receptor Agonists Industry Partner contract with Oregon Health & Science University is valued at $300,386, covering research grant work.
What type of contract is this?
This is a Research Grant contract, documented as a agendapacket record.
Where was this contract approved?
This contract appears in OHSU Board of Directors Agenda Packet January 2026 (AgendaPacket), dated January 22, 2026 from Oregon Health & Science University. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What other contracts does Melanocortin-4 Receptor Agonists Industry Partner hold?
Melanocortin-4 Receptor Agonists Industry Partner may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
View Melanocortin-4 Receptor Agonists Industry Partner's profileWhat is Oregon Health & Science University currently buying?
Explore Oregon Health & Science University's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.
View Oregon Health & Science University's profile